FAT10 is a proteasomal degradation signal that is itself regulated by ubiquitination

Molecular Biology of the Cell

Volumn 23, Issue 1, 2012, Pages 225-232

  Buchsbaum, Samuel ^a   Bercovich, Beatrice ^a   Ciechanover, Aaron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FAT10 PROTEIN; PROTEASOME; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME 13; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MUTANT; CELL STRAIN HEK293; CHO CELL; HUMAN; HUMAN CELL; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION; WILD TYPE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CELL-FREE SYSTEM; CHO CELLS; CRICETINAE; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LEUPEPTINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STABILITY; PROTEOLYSIS; RECOMBINANT FUSION PROTEINS; UBIQUITINATION; UBIQUITINS;

VERTEBRATA;

EID: 84855413453     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-07-0609     Document Type: Article

References (33)

1. Bernal-Bayard J, Ramos-Morales F (2009). Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin. J Biol Chem 284, 27587-27595.
2. Breitschopf K, Bengal E, Ziv T, Admon A, Ciechanover A (1998). A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J 17, 5964-5973. (Pubitemid 28474790)
3. Canaan A et al. (2006). FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol 26, 5180-5189. (Pubitemid 43955829)
4. Carlson N, Rechsteiner M (1987). Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions. J Cell Biol 104, 537-546. (Pubitemid 17024708)
5. Chen ZJ, Sun LJ (2009). Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33, 275-286.
6. Chiu YH, Sun Q, Chen ZJ (2007). E1-L2 activates both ubiquitin and FAT10. Mol Cell 27, 1014-1023. (Pubitemid 47488190)
7. Dokmanovic M, Chang BD, Fang J, Roninson IB (2002). Retinoid-induced growth arrest of breast carcinoma cells involves co-activation of multiple growth-inhibitory genes. Cancer Biol Ther 1, 24-27.
8. Fan W, Cai W, Parimoo S, Schwarz DC, Lennon GG, Weissman SM (1996). Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 44, 97-103. (Pubitemid 26164207)
9. Glickman MH, Ciechanover A (2002). The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82, 373-428. (Pubitemid 34654457)
10. Gruen JR et al. (1996). A transcription map of the major histocompatibility complex (MHC) class I region. Genomics 36, 70-85. (Pubitemid 26277760)
11. Hershko A, Rose IA (1987). Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. Proc Natl Acad Sci USA 84, 1829-1833. (Pubitemid 17054106)
12. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G (2005). FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol 25, 3483-3491. (Pubitemid 40559557)
13. Hipp MS, Raasi S, Groettrup M, Schmidtke G (2004). NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J Biol Chem 279, 16503-16510. (Pubitemid 38509349)
14. Hiroi Y, Rechsteiner M (1992). Ubiquitin metabolism in HeLa cells starved of amino acids. FEBS Lett 307, 156-161.
15. Hochstrasser M (2009). Origin and function of ubiquitin-like proteins. Nature 458, 422-429.
16. Kalveram B, Schmidtke G, Groettrup M (2008). The ubiquitin-like modifier FAT10 interacts with HDAC6 and localizes to aggresomes under proteasome inhibition. J Cell Sci 121, 4079-4088.
17. Kulka RG, Raboy B, Schuster R, Parag HA, Diamond G, Ciechanover A, Marcus M (1988). A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. J Biol Chem 263, 15726-15731.
18. Lee CG et al. (2003). Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22, 2592-2603. (Pubitemid 36605607)
19. Lim CB, Zhang D, Lee CG (2006). FAT10, a gene up-regulated in various cancers, is cell-cycle regulated. Cell Div 1, 20.
20. Liu YC, Pan J, Zhang C, Fan W, Collinge M, Bender JR, Weissman SM (1999). A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2. Proc Natl Acad Sci USA 96, 4313-4318. (Pubitemid 29190333)
21. Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P, Breuhahn K, Groettrup M (2008). Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 27, 6068-6074.
22. Niwa H, Yamamura K, Miyazaki J (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
23. Qian SB, Princiotta MF, Bennink JR, Yewdell JW (2006). Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J Biol Chem 281, 392-400. (Pubitemid 43671200)
24. Raasi S, Schmidtke G, Groettrup M (2001). The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem 276, 35334-35343.
25. Ren J, Kan A, Leong SH, Ooi LL, Jeang KT, Chong SS, Kon OL, Lee CG (2006). FAT10 plays a role in the regulation of chromosomal stability. J Biol Chem 281, 11413-11421. (Pubitemid 43855566)
26. Ross MJ et al. (2006). Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol 17, 996-1004.
27. Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS, Groettrup M (2006). The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J Biol Chem 281, 20045-20054. (Pubitemid 44065779)
28. Shabek N, Herman-Bachinsky Y, Ciechanover A (2009). Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation. Proc Natl Acad Sci USA 106, 11907-11912.
29. Tanaka T, Kawashima H, Yeh ET, Kamitani T (2003). Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J Biol Chem 278, 32905-32913. (Pubitemid 37055733)
30. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, Palvimo JJ, Hay RT (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10, 538-546. (Pubitemid 351627373)
31. Verhoef LG, Heinen C, Selivanova A, Halff EF, Salomons FA, Dantuma NP (2009). Minimal length requirement for proteasomal degradation of ubiquitin-dependent substrates. FASEB J 23, 123-133.
32. Welchman RL, Gordon C, Mayer RJ (2005). Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6, 599-609. (Pubitemid 41081264)
33. Zhang DW, Jeang KT, Lee CG (2006). p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 25, 2318-2327.